Work

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Year: 2015

Type: article

Study design: Observational Study

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.07.641

Authors: Syed M. Kazmi, Maliha Nusrat, Hilal Gunaydin, Amanda M. Cornelison, Nina Shah, Partow Kebriaei, Yago Nieto, Simrit Parmar, Uday R. Popat, Betul Oran, Jatin J. Shah, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash, Qaiser Bashir

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center at Houston

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Center for Clinical and Translational Sciences (CCTS), G580208524, Cancer Center Support Grant

OpenAlex ID: W2175133478

FWCI: 3.125

Cites: 22

Cited by: 44

Related to: 10